Advertisement
Quick Menu

Upcoming Journals

British Journal of Medicine and Medical Research

British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol.: 18, Issue.: 3

Case Study

Maxillary Clear Cell Odontogenic Carcinoma - A Rare Entity

 

T. L. Yogesh1, Hema Keswani1*, Akshay Shetty2 and Hemavathy S1

1Department of Oral and Maxillofacial Pathology, Sri Rajiv Gandhi College of Dental Sciences and Hospital, Cholanagar, Hebbal, Bangalore-560032, Karnataka, India.

2Department of Oral and Maxillofacial Surgery, Sri Rajiv Gandhi College of Dental Sciences and Hospital, Bangalore-560032, Karnataka, India.

 

Article Information
Editor(s):
(1) James Anthony Giglio, Adjunct Clinical Professor of Oral and Maxillofacial Surgery, School of Dentistry, Virginia Commonwealth University, Virginia, USA.
Reviewers:
(1) Maya Ramesh, Vinayaka Missions Sankarachariyar Dental Colege, Vinayaka University, India.
(2) Shoko Gamoh, Osaka Dental University, Japan.
Complete Peer review History: http://www.sciencedomain.org/review-history/16517

 

Abstracts

 

Clear cell odontogenic carcinoma (CCOC) is a rare odontogenic tumor with predominance in the posterior mandible, usually occurring in the fifth to seventh decades of life, and being found more commonly in females. It is a potentially aggressive tumour, capable of recurring frequently, locally invasive, and with distant metastases. Here we report a case of clear cell odontogenic carcinoma of maxilla in a 70 years old female, with a tumor mass on right side of the palate in the premolar - molar region. Microscopically, biphasic population of cells with characteristic polygonal, clear cells, hyperchromatic and basaloid cells with eosinophillic cytoplasm were seen. There was positive immunoreactivity with markers Ki67 and cytokeratin CK19. The significance of histochemical and immunohistochemical resources in the correct diagnosis of CCOC is presented.

 

Keywords :

Clear cell odontogenic carcinoma; clear cell; maxilla.

 

Full Article - PDF    Page 1-5    Article Metrics

 

DOI : 10.9734/BJMMR/2016/27190

Review History    Comments

Search this site

Advanced Search

Announcement & News

Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and its editors

We are happy to inform that Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and ...

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.